| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |